Back to mobile site

More on INMB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.4 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INmune Bio (NQ:INMB)
Delayed: 1.21 --0 (-0%)
Prev. Close $1.21  
Open$1.21 
52 Wk High$ 
52 Wk Low$ 
Day High$1.21 
Day Low$1.21 
P/E N/A  
EPS$ 
Volume4,595 


Jun 2, 2026 04:00 PM Form 8-K Inmune Bio, Inc. For: Jun 02
Jun 2, 2026 08:01 AM INmune Bio reports positive MRI results in Alzheimer's trial
Jun 2, 2026 08:00 AM INmune Bio reports positive MRI results in Alzheimer's trial
Jun 2, 2026 08:00 AM INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
Jun 2, 2026 08:00 AM INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
May 15, 2026 08:00 AM INmune Bio publishes Phase 2 Alzheimer's trial results in peer-reviewed journal
May 15, 2026 08:00 AM INmune Bio publishes phase 2 alzheimer's trial results in peer journal
May 15, 2026 08:00 AM INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May 14, 2026 04:06 PM Form 8-K Inmune Bio, Inc. For: May 14
May 14, 2026 08:00 AM INmune Bio receives FDA fast track designation for alzheimer's drug
View All Articles

Entities mentioned with INMB

View All Entities